Polaryx Therapeutics, Inc. Share Price
NASDAQ: PLYX | Micro CapPolaryx Therapeutics, Inc. Stock Performance
Polaryx Therapeutics, Inc. Share Price Today
As of 29 October 2026, Polaryx Therapeutics, Inc.'s share price is $1.88. The stock opened at $1.88, compared to its previous close of $1.83. During today's trading session, Polaryx Therapeutics, Inc.'s share price traded between $1.88 and $1.88, with an average price of $1.88. Over the past 52 weeks, the stock has recorded a high of $34.69 and a low of $1.77. In terms of performance, Polaryx Therapeutics, Inc.'s share price has declined by 64.12% over the last six months and is down 40.41% on a year-on-year basis.
Polaryx Therapeutics, Inc. Share Price Chart
Polaryx Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
About Polaryx Therapeutics, Inc.
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Polaryx Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.00 | $1.88 | -10.05% |
Sep 2026 | $2.00 | $2.09 | +0.48% |
Aug 2026 | $2.28 | $2.08 | -10.34% |
Jul 2026 | $2.66 | $2.32 | -12.12% |
Jun 2026 | $3.27 | $2.64 | -19.51% |
May 2026 | $5.11 | $3.28 | -37.40% |
Apr 2026 | $7.57 | $5.24 | -30.87% |
Mar 2026 | $2.82 | $7.58 | +140.25% |
Feb 2026 | $34.69 | $3.15 | N/A |